Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 13/20 | 0.79 |
| ▸ | PPARA | Q07869 | 15/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5913369 | 0.91 | PPARG (0.95) | PPARGPPARASIGMAR1NPC1RAB9A | |
| SCHEMBL6450149 | 0.91 | PPARG (0.85) | PPARGPPARASIGMAR1NPC1RAB9A | |
| SCHEMBL5913710 | 0.91 | PPARG (0.65) | PPARGPPARANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5914099 | 0.89 | PPARG (0.65) | PPARGPPARA | |
| SCHEMBL5913603 | 0.88 | PPARG (1.00) | PPARGPPARASIGMAR1NPC1RAB9A | |
| SCHEMBL29496192 | 0.88 | PPARG (1.00) | PPARGPPARASIGMAR1NPC1RAB9A | |
| SCHEMBL7021537 | 0.88 | PPARG (0.81) | PPARGPPARASIGMAR1NPC1RAB9A | |
| SCHEMBL5727544 | 0.87 | PPARG (0.69) | PPARGPPARASIGMAR1 | |
| SCHEMBL5727326 | 0.87 | PPARG (0.66) | PPARGPPARASIGMAR1NPC1RAB9A | |
| SCHEMBL6452002 | 0.87 | PPARG (0.81) | PPARGPPARASIGMAR1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060111407-A1 | Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111407-A1 | Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity | PC, GPR119, LIPC | PPARG 19/4885PPARA 44/4885SIGMAR1 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.